Selected research
Industry Growth & Trends
Global Valsartan-Hydrochlorothiazide Industry Growth and Trends Forecast to 2032
Market perspective
The global Valsartan-Hydrochlorothiazide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Valsartan-Hydrochlorothiazide include Teva, Novartis, Mylan, Huaren Pharmaceutical, Zhejiang Huahai Pharmaceutical, Torrent Pharmaceuticals, Par Pharmaceutical, MACLEODS and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Valsartan-Hydrochlorothiazide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Valsartan-Hydrochlorothiazide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valsartan-Hydrochlorothiazide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valsartan-Hydrochlorothiazide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Valsartan-Hydrochlorothiazide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Valsartan-Hydrochlorothiazide Market by Company
Teva
Novartis
Mylan
Huaren Pharmaceutical
Zhejiang Huahai Pharmaceutical
Torrent Pharmaceuticals
Par Pharmaceutical
MACLEODS
Lupin
Cisen Pharmaceutical
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Aurobindo Pharma
APOTEX
Alembic Pharmaceuticals
Valsartan-Hydrochlorothiazide Segment by Type
Tablet
Capsule
Valsartan-Hydrochlorothiazide Segment by Application
Hospital
Drug Store
Valsartan-Hydrochlorothiazide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan-Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan-Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan-Hydrochlorothiazide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Valsartan-Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Novartis
- Mylan
- Huaren Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Torrent Pharmaceuticals
- Par Pharmaceutical
- MACLEODS
- Lupin
- Cisen Pharmaceutical
- Chongqing Conquer Pharmaceutical
- Beijing Second Pharmaceutical
- Aurobindo Pharma
- APOTEX
- Alembic Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Valsartan-Hydrochlorothiazide Sales Estimates and Forecasts (2021-2032)
- 1.3 Valsartan-Hydrochlorothiazide Market by Type
- 1.3.1 Tablet
- 1.3.2 Capsule
- 1.4 Global Valsartan-Hydrochlorothiazide Market Size by Type
- 1.4.1 Global Valsartan-Hydrochlorothiazide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Valsartan-Hydrochlorothiazide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Valsartan-Hydrochlorothiazide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Valsartan-Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Valsartan-Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Valsartan-Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Valsartan-Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Valsartan-Hydrochlorothiazide Industry Trends
- 2.2 Valsartan-Hydrochlorothiazide Industry Drivers
- 2.3 Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges
- 2.4 Valsartan-Hydrochlorothiazide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Valsartan-Hydrochlorothiazide Revenue (2021-2026)
- 3.2 Global Top Players by Valsartan-Hydrochlorothiazide Sales (2021-2026)
- 3.3 Global Top Players by Valsartan-Hydrochlorothiazide Price (2021-2026)
- 3.4 Global Valsartan-Hydrochlorothiazide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Valsartan-Hydrochlorothiazide Major Company Production Sites & Headquarters
- 3.6 Global Valsartan-Hydrochlorothiazide Company, Product Type & Application
- 3.7 Global Valsartan-Hydrochlorothiazide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Valsartan-Hydrochlorothiazide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Valsartan-Hydrochlorothiazide Players Market Share by Revenue in 2025
- 3.8.3 2025 Valsartan-Hydrochlorothiazide Tier 1, Tier 2, and Tier 3
4 Valsartan-Hydrochlorothiazide Regional Status and Outlook
- 4.1 Global Valsartan-Hydrochlorothiazide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Valsartan-Hydrochlorothiazide Historic Market Size by Region
- 4.2.1 Global Valsartan-Hydrochlorothiazide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Valsartan-Hydrochlorothiazide Sales in Value by Region (2021-2026)
- 4.2.3 Global Valsartan-Hydrochlorothiazide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Valsartan-Hydrochlorothiazide Forecasted Market Size by Region
- 4.3.1 Global Valsartan-Hydrochlorothiazide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Valsartan-Hydrochlorothiazide Sales in Value by Region (2027-2032)
- 4.3.3 Global Valsartan-Hydrochlorothiazide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valsartan-Hydrochlorothiazide by Application
- 5.1 Valsartan-Hydrochlorothiazide Market by Application
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.2 Global Valsartan-Hydrochlorothiazide Market Size by Application
- 5.2.1 Global Valsartan-Hydrochlorothiazide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Valsartan-Hydrochlorothiazide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Valsartan-Hydrochlorothiazide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Valsartan-Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Valsartan-Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Valsartan-Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Valsartan-Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Mylan
- 6.3.1 Mylan Company Information
- 6.3.2 Mylan Business Overview
- 6.3.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
- 6.3.5 Mylan Recent Developments
- 6.4 Huaren Pharmaceutical
- 6.4.1 Huaren Pharmaceutical Company Information
- 6.4.2 Huaren Pharmaceutical Business Overview
- 6.4.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.4.5 Huaren Pharmaceutical Recent Developments
- 6.5 Zhejiang Huahai Pharmaceutical
- 6.5.1 Zhejiang Huahai Pharmaceutical Company Information
- 6.5.2 Zhejiang Huahai Pharmaceutical Business Overview
- 6.5.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.5.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 6.6 Torrent Pharmaceuticals
- 6.6.1 Torrent Pharmaceuticals Company Information
- 6.6.2 Torrent Pharmaceuticals Business Overview
- 6.6.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
- 6.6.5 Torrent Pharmaceuticals Recent Developments
- 6.7 Par Pharmaceutical
- 6.7.1 Par Pharmaceutical Company Information
- 6.7.2 Par Pharmaceutical Business Overview
- 6.7.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.7.5 Par Pharmaceutical Recent Developments
- 6.8 MACLEODS
- 6.8.1 MACLEODS Company Information
- 6.8.2 MACLEODS Business Overview
- 6.8.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
- 6.8.5 MACLEODS Recent Developments
- 6.9 Lupin
- 6.9.1 Lupin Company Information
- 6.9.2 Lupin Business Overview
- 6.9.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
- 6.9.5 Lupin Recent Developments
- 6.10 Cisen Pharmaceutical
- 6.10.1 Cisen Pharmaceutical Company Information
- 6.10.2 Cisen Pharmaceutical Business Overview
- 6.10.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.10.5 Cisen Pharmaceutical Recent Developments
- 6.11 Chongqing Conquer Pharmaceutical
- 6.11.1 Chongqing Conquer Pharmaceutical Company Information
- 6.11.2 Chongqing Conquer Pharmaceutical Business Overview
- 6.11.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.11.5 Chongqing Conquer Pharmaceutical Recent Developments
- 6.12 Beijing Second Pharmaceutical
- 6.12.1 Beijing Second Pharmaceutical Company Information
- 6.12.2 Beijing Second Pharmaceutical Business Overview
- 6.12.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 6.12.5 Beijing Second Pharmaceutical Recent Developments
- 6.13 Aurobindo Pharma
- 6.13.1 Aurobindo Pharma Company Information
- 6.13.2 Aurobindo Pharma Business Overview
- 6.13.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
- 6.13.5 Aurobindo Pharma Recent Developments
- 6.14 APOTEX
- 6.14.1 APOTEX Company Information
- 6.14.2 APOTEX Business Overview
- 6.14.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
- 6.14.5 APOTEX Recent Developments
- 6.15 Alembic Pharmaceuticals
- 6.15.1 Alembic Pharmaceuticals Company Information
- 6.15.2 Alembic Pharmaceuticals Business Overview
- 6.15.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
- 6.15.5 Alembic Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Valsartan-Hydrochlorothiazide Sales by Country
- 7.1.1 North America Valsartan-Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
- 7.1.3 North America Valsartan-Hydrochlorothiazide Sales Forecast by Country (2027-2032)
- 7.2 North America Valsartan-Hydrochlorothiazide Market Size by Country
- 7.2.1 North America Valsartan-Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Valsartan-Hydrochlorothiazide Market Size by Country (2021-2026)
- 7.2.3 North America Valsartan-Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Valsartan-Hydrochlorothiazide Sales by Country
- 8.1.1 Europe Valsartan-Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
- 8.1.3 Europe Valsartan-Hydrochlorothiazide Sales Forecast by Country (2027-2032)
- 8.2 Europe Valsartan-Hydrochlorothiazide Market Size by Country
- 8.2.1 Europe Valsartan-Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Valsartan-Hydrochlorothiazide Market Size by Country (2021-2026)
- 8.2.3 Europe Valsartan-Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Valsartan-Hydrochlorothiazide Sales by Country
- 9.1.1 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Valsartan-Hydrochlorothiazide Market Size by Country
- 9.2.1 Asia-Pacific Valsartan-Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Valsartan-Hydrochlorothiazide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Valsartan-Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Valsartan-Hydrochlorothiazide Sales by Country
- 10.1.1 South America Valsartan-Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
- 10.1.3 South America Valsartan-Hydrochlorothiazide Sales Forecast by Country (2027-2032)
- 10.2 South America Valsartan-Hydrochlorothiazide Market Size by Country
- 10.2.1 South America Valsartan-Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Valsartan-Hydrochlorothiazide Market Size by Country (2021-2026)
- 10.2.3 South America Valsartan-Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country
- 11.1.1 Middle East and Africa Valsartan-Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Valsartan-Hydrochlorothiazide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country
- 11.2.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Valsartan-Hydrochlorothiazide Value Chain Analysis
- 12.1.1 Valsartan-Hydrochlorothiazide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Valsartan-Hydrochlorothiazide Production Mode & Process
- 12.2 Valsartan-Hydrochlorothiazide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Valsartan-Hydrochlorothiazide Distributors
- 12.2.3 Valsartan-Hydrochlorothiazide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst